Enabling you to identify and mitigate the intrinsic risk in your operations, supply chains and business processes.
Evaluating how your products and services meet and exceed quality, safety, sustainability and performance standards.
Validating the specifications, value and safety of your raw materials, products and assets.
In-vitro testing approaches are invaluable to the support the development of this product class allowing a deep understanding of critical quality attributes (CQAs). In this webinar, Mervin Ramjeeawon, Team Leader, will present an in-depth review of the in-vitro testing required for nasal drug products including USP / EP testing requirements, typical analytical approaches, set-up, testing considerations and typical stability programmes with a particular focus on spray characterisation & particle sizing (DSD, spray pattern, plume geometry, morphologically directed Raman spectroscopy).
June 27, 2019 | 16:00 CEST, 15:00 BST, 10:00 EDT
Register now by completing the form below
Scheduling conflict? Register anyway to access the post-event recording